Primate models of Parkinson's disease

Exp Neurol. 2003 Oct;183(2):258-62. doi: 10.1016/s0014-4886(03)00246-2.
No abstract available

Publication types

  • Comment
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Aging
  • Animals
  • Corpus Striatum / drug effects
  • Corpus Striatum / pathology
  • Disease Models, Animal
  • Humans
  • Oxidopamine
  • Parkinsonian Disorders / chemically induced
  • Parkinsonian Disorders / pathology
  • Parkinsonian Disorders / physiopathology*
  • Primates
  • Reproducibility of Results
  • Substantia Nigra / drug effects
  • Substantia Nigra / pathology

Substances

  • Oxidopamine
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine